ANGIODYNAMICS INC (ANGO) Fundamental Analysis & Valuation

NASDAQ:ANGO • US03475V1017

Current stock price

9.84 USD
-0.47 (-4.56%)
At close:
9.8094 USD
-0.03 (-0.31%)
After Hours:

This ANGO fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. ANGO Profitability Analysis

1.1 Basic Checks

  • In the past year ANGO has reported negative net income.
  • In the past year ANGO has reported a negative cash flow from operations.
  • In the past 5 years ANGO always reported negative net income.
  • In multiple years ANGO reported negative operating cash flow during the last 5 years.
ANGO Yearly Net Income VS EBIT VS OCF VS FCFANGO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M -100M -150M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -10.28%, ANGO is in the better half of the industry, outperforming 60.64% of the companies in the same industry.
  • ANGO's Return On Equity of -15.71% is fine compared to the rest of the industry. ANGO outperforms 63.30% of its industry peers.
Industry RankSector Rank
ROA -10.28%
ROE -15.71%
ROIC N/A
ROA(3y)-26.67%
ROA(5y)-18.08%
ROE(3y)-40.7%
ROE(5y)-27.1%
ROIC(3y)N/A
ROIC(5y)N/A
ANGO Yearly ROA, ROE, ROICANGO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -20 -40 -60 -80

1.3 Margins

  • ANGO has a Gross Margin of 54.58%. This is comparable to the rest of the industry: ANGO outperforms 53.19% of its industry peers.
  • In the last couple of years the Gross Margin of ANGO has remained more or less at the same level.
  • ANGO does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 54.58%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.95%
GM growth 5Y-1.07%
ANGO Yearly Profit, Operating, Gross MarginsANGO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40 -60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. ANGO Health Analysis

2.1 Basic Checks

  • ANGO does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • ANGO has more shares outstanding than it did 1 year ago.
  • ANGO has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for ANGO is higher compared to a year ago.
ANGO Yearly Shares OutstandingANGO Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M
ANGO Yearly Total Debt VS Total AssetsANGO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

2.2 Solvency

  • ANGO has an Altman-Z score of 1.70. This is a bad value and indicates that ANGO is not financially healthy and even has some risk of bankruptcy.
  • ANGO has a Altman-Z score of 1.70. This is comparable to the rest of the industry: ANGO outperforms 54.79% of its industry peers.
  • ANGO has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.
  • ANGO's Debt to Equity ratio of 0.03 is fine compared to the rest of the industry. ANGO outperforms 70.21% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z 1.7
ROIC/WACCN/A
WACC8.96%
ANGO Yearly LT Debt VS Equity VS FCFANGO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M

2.3 Liquidity

  • A Current Ratio of 2.24 indicates that ANGO has no problem at all paying its short term obligations.
  • ANGO's Current ratio of 2.24 is in line compared to the rest of the industry. ANGO outperforms 42.55% of its industry peers.
  • A Quick Ratio of 1.33 indicates that ANGO should not have too much problems paying its short term obligations.
  • With a Quick ratio value of 1.33, ANGO is not doing good in the industry: 64.89% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 2.24
Quick Ratio 1.33
ANGO Yearly Current Assets VS Current LiabilitesANGO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. ANGO Growth Analysis

3.1 Past

  • ANGO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 38.89%, which is quite impressive.
  • The Revenue has decreased by -3.76% in the past year.
  • Measured over the past years, ANGO shows a small growth in Revenue. The Revenue has been growing by 2.06% on average per year.
EPS 1Y (TTM)38.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-33.33%
Revenue 1Y (TTM)-3.76%
Revenue growth 3Y-2.56%
Revenue growth 5Y2.06%
Sales Q2Q%8.91%

3.2 Future

  • Based on estimates for the next years, ANGO will show a very strong growth in Earnings Per Share. The EPS will grow by 33.95% on average per year.
  • Based on estimates for the next years, ANGO will show a small growth in Revenue. The Revenue will grow by 5.85% on average per year.
EPS Next Y-97.2%
EPS Next 2Y11.89%
EPS Next 3Y50.78%
EPS Next 5Y33.95%
Revenue Next Year9.15%
Revenue Next 2Y7.02%
Revenue Next 3Y6.49%
Revenue Next 5Y5.85%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ANGO Yearly Revenue VS EstimatesANGO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 100M 200M 300M
ANGO Yearly EPS VS EstimatesANGO Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.2 -0.2 0.4 -0.4 0.6 0.8

More info and screens

Find the best growth stocksShow best growing peers

1

4. ANGO Valuation Analysis

4.1 Price/Earnings Ratio

  • ANGO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ANGO. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ANGO Price Earnings VS Forward Price EarningsANGO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40 -60 -80

4.2 Price Multiples

  • ANGO's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. ANGO is cheaper than 63.83% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 123.17
ANGO Per share dataANGO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

  • ANGO's earnings are expected to grow with 50.78% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y11.89%
EPS Next 3Y50.78%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ANGO Dividend Analysis

5.1 Amount

  • ANGO does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ANGO Fundamentals: All Metrics, Ratios and Statistics

ANGIODYNAMICS INC

NASDAQ:ANGO (4/6/2026, 8:20:57 PM)

After market: 9.8094 -0.03 (-0.31%)

9.84

-0.47 (-4.56%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)04-02
Earnings (Next)07-13
Inst Owners96.34%
Inst Owner Change0%
Ins Owners12%
Ins Owner Change0.68%
Market Cap405.60M
Revenue(TTM)292.50M
Net Income(TTM)-27.71M
Analysts84
Price Target19.72 (100.41%)
Short Float %4.94%
Short Ratio4.44
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)58.28%
Min EPS beat(2)16.56%
Max EPS beat(2)100%
EPS beat(4)4
Avg EPS beat(4)78.67%
Min EPS beat(4)16.56%
Max EPS beat(4)122.62%
EPS beat(8)7
Avg EPS beat(8)56.78%
EPS beat(12)9
Avg EPS beat(12)16.11%
EPS beat(16)12
Avg EPS beat(16)37.25%
Revenue beat(2)2
Avg Revenue beat(2)2.06%
Min Revenue beat(2)2.06%
Max Revenue beat(2)2.06%
Revenue beat(4)4
Avg Revenue beat(4)2.59%
Min Revenue beat(4)0.41%
Max Revenue beat(4)5.83%
Revenue beat(8)5
Avg Revenue beat(8)0.5%
Revenue beat(12)5
Avg Revenue beat(12)-0.72%
Revenue beat(16)6
Avg Revenue beat(16)-1%
PT rev (1m)0%
PT rev (3m)4.5%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-22.22%
EPS NY rev (1m)0%
EPS NY rev (3m)12.12%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.13%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.86%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.32
P/FCF N/A
P/OCF N/A
P/B 2.3
P/tB 3.7
EV/EBITDA 123.17
EPS(TTM)-0.11
EYN/A
EPS(NY)-0.11
Fwd EYN/A
FCF(TTM)-0.23
FCFYN/A
OCF(TTM)-0.14
OCFYN/A
SpS7.46
BVpS4.28
TBVpS2.66
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -10.28%
ROE -15.71%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 54.58%
FCFM N/A
ROA(3y)-26.67%
ROA(5y)-18.08%
ROE(3y)-40.7%
ROE(5y)-27.1%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.95%
GM growth 5Y-1.07%
F-Score5
Asset Turnover1.14
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA 1.77
Cap/Depr 15.59%
Cap/Sales 1.21%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.24
Quick Ratio 1.33
Altman-Z 1.7
F-Score5
WACC8.96%
ROIC/WACCN/A
Cap/Depr(3y)17.4%
Cap/Depr(5y)17.38%
Cap/Sales(3y)1.57%
Cap/Sales(5y)1.57%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)38.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-33.33%
EPS Next Y-97.2%
EPS Next 2Y11.89%
EPS Next 3Y50.78%
EPS Next 5Y33.95%
Revenue 1Y (TTM)-3.76%
Revenue growth 3Y-2.56%
Revenue growth 5Y2.06%
Sales Q2Q%8.91%
Revenue Next Year9.15%
Revenue Next 2Y7.02%
Revenue Next 3Y6.49%
Revenue Next 5Y5.85%
EBIT growth 1Y34.63%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year151.66%
EBIT Next 3Y59.83%
EBIT Next 5Y38.19%
FCF growth 1Y-46.5%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-69.57%
OCF growth 3YN/A
OCF growth 5YN/A

ANGIODYNAMICS INC / ANGO Fundamental Analysis FAQ

What is the fundamental rating for ANGO stock?

ChartMill assigns a fundamental rating of 2 / 10 to ANGO.


What is the valuation status of ANGIODYNAMICS INC (ANGO) stock?

ChartMill assigns a valuation rating of 1 / 10 to ANGIODYNAMICS INC (ANGO). This can be considered as Overvalued.


What is the profitability of ANGO stock?

ANGIODYNAMICS INC (ANGO) has a profitability rating of 2 / 10.


What is the expected EPS growth for ANGIODYNAMICS INC (ANGO) stock?

The Earnings per Share (EPS) of ANGIODYNAMICS INC (ANGO) is expected to decline by -97.2% in the next year.